Abstract:Abstract Background Genome-wide association studies have identified genetic variants associated with the risk of brain-related diseases, such as neurological and psychiatric disorders, while the causal variants and the specific vulnerable cell types are often needed to be studied. Many disease-associated genes are expressed in multiple cell types of human brains, while the pathologic variants affect primarily specific cell types. We hypothesize a model in which what determines the manifestation of a disease in a cell type is the presence of disease module comprised of disease-associated genes, instead of individual genes. Therefore, it is essential to identify the presence/absence of disease gene modules in cells. Methods To characterize the cell type-specificity of brain-related diseases, we construct human brain cell type-specific gene interaction networks integrating human brain nucleus gene expression data with a referenced tissue-specific gene interaction network. Then from the cell type-specific gene interaction networks, we identify significant cell type-specific disease gene modules by performing statistical tests. Results Between neurons and glia cells, the constructed cell type-specific gene networks and their gene functions are distinct. Then we identify cell type-specific disease gene modules associated with autism spectrum disorder and find that different gene modules are formed and distinct gene functions may be dysregulated in different cells. We also study the similarity and dissimilarity in cell type-specific disease gene modules among autism spectrum disorder, schizophrenia and bipolar disorder. The functions of neurons-specific disease gene modules are associated with synapse for all three diseases, while those in glia cells are different. To facilitate the use of our method, we develop an R package, CtsDGM, for the identification of cell type-specific disease gene modules. Conclusions The results support our hypothesis that a disease manifests itself in a cell type through forming a statistically significant disease gene module. The identification of cell type-specific disease gene modules can promote the development of more targeted biomarkers and treatments for the disease. Our method can be applied for depicting the cell type heterogeneity of a given disease, and also for studying the similarity and dissimilarity between different disorders, providing new insights into the molecular mechanisms underlying the pathogenesis and progression of diseases.

Additional File 1 of an Analytical Method for the Identification of Cell Type-Specific Disease Gene Modules

An analytical method for the identification of cell type-specific disease gene modules

Additional File 5 of Deep Learning for Cancer Type Classification and Driver Gene Identification

Additional File 8 of the Immune Subtypes and Landscape of Sarcomas

Additional File 14 of A Single-Cell Survey of Cellular Hierarchy in Acute Myeloid Leukemia

Additional File 2 of A Deep Generative Model for Multi-View Profiling of Single-Cell RNA-seq and ATAC-seq Data

Additional File 11 of Single-cell Transcriptome Profiling of an Adult Human Cell Atlas of 15 Major Organs

Supplementary Figure S10 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study

Additional File 2 of Online Database for Brain Cancer-Implicated Genes: Exploring the Subtype-Specific Mechanisms of Brain Cancer

Additional file 2 – The biological support of the gene regulations for Yeast cell cycling

Additional File 2 of Predicting Disease-Related Genes Using Integrated Biomedical Networks

Additional File 3: Table S2. of A Novel Integrated Gene Coexpression Analysis Approach Reveals a Prognostic Three-Transcription-factor Signature for Glioma Molecular Subtypes

Additional File 2 of Characterizing Sensitivity and Coverage of Clinical WGS As a Diagnostic Test for Genetic Disorders

Additional File 5 of Molecular Profiling of Human Non-Small Cell Lung Cancer by Single-Cell RNA-seq

Additional File 11 of A Novel Signature Derived from Metabolism-Related Genes GPT and SMS to Predict Prognosis of Laryngeal Squamous Cell Carcinoma

Additional File 2 of Identification and Validation of a Six-Gene Signature Associated with Glycolysis to Predict the Prognosis of Patients with Cervical Cancer

Additional File 4: Table S3. of Comprehensive Analyses of Tumor Immunity: Implications for Cancer Immunotherapy

Additional File 4: of Molecular and Clinical Characterization of PTPN2 Expression from RNA-seq Data of 996 Brain Gliomas

Additional File 5 of Identification of Cell Subpopulations Associated with Disease Phenotypes from Scrna-Seq Data Using PACSI

Additional File 5 of Single-cell Morphological Characterization of CRH Neurons Throughout the Whole Mouse Brain

Additional File 2 of ICGEC: a Comparative Method for Measuring Epigenetic Conservation of Genes Via the Integrated Signal from Multiple Histone Modifications Between Cell Types